<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39340068</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Enhancing COVID-19 Vaccination Awareness and Uptake in the Post-PHEIC Era: A Narrative Review of Physician-Level and System-Level Strategies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1038</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12091038</ELocationID><Abstract><AbstractText>Following the World Health Organization's declaration that the COVID-19 pandemic is no longer a public health emergency of international concern (PHEIC), COVID-19 remains an ongoing threat to human health and healthcare systems. Vaccination plays a crucial role in reducing the disease's incidence, mitigating its severity, and limiting transmission, contributing to long-term public health resilience. However, incomplete vaccination coverage and vaccine hesitancy exist. This narrative review investigates strategies at the system and physician levels aimed at sustaining awareness and uptake of COVID-19 vaccination in a post-PHEIC era. Through an examination of the existing literature, this review explores the effectiveness of diverse approaches utilized by healthcare systems and individual providers. These approaches address every component of the 5C model of vaccine hesitancy: confidence, complacency, constraints/convenience, calculation, and collective responsibility. Physician-level approaches include appropriate message framing, persuasive communication containing safety and personal/social benefit information, sharing of personal stories, creating a safe space for discussion, harnessing co-administration with annual influenza vaccines, and use of decision aids and visual messages. System-level approaches include messaging, mass media for health communication, on-site vaccine availability, pharmacist delivery, healthcare protocol integration, incentives, and chatbot use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>See</LastName><ForeName>Kay Choong</ForeName><Initials>KC</Initials><Identifier Source="ORCID">0000-0003-2528-7282</Identifier><AffiliationInfo><Affiliation>Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore 119074, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">pandemic preparedness</Keyword><Keyword MajorTopicYN="N">public health</Keyword><Keyword MajorTopicYN="N">vaccination hesitancy</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The author declares honoraria from AstraZeneca, GSK, Moderna, and Pfizer.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39340068</ArticleId><ArticleId IdType="pmc">PMC11435511</ArticleId><ArticleId IdType="doi">10.3390/vaccines12091038</ArticleId><ArticleId IdType="pii">vaccines12091038</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ulrichs T., Rolland M., Wu J., Nunes M.C., El Guerche-Seblain C., Chit A. Changing Epidemiology of COVID-19: Potential Future Impact on Vaccines and Vaccination Strategies. Expert Rev. Vaccines. 2024;23:510–522. doi: 10.1080/14760584.2024.2346589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2024.2346589</ArticleId><ArticleId IdType="pubmed">38656834</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy D.N., Ferdiousi N., Mohabbot Hossen M., Islam E., Shah Azam M. Global Disparities in COVID-19 Vaccine Booster Dose (Vbd) Acceptance and Hesitancy: An Updated Narrative Review. Vaccine X. 2024;18:100480. doi: 10.1016/j.jvacx.2024.100480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2024.100480</ArticleId><ArticleId IdType="pmc">PMC10997838</ArticleId><ArticleId IdType="pubmed">38585380</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahidy F.S., Drews A.L., Masud F.N., Schwartz R.L., Askary B.B., Boom M.L., Phillips R.A. Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area. JAMA. 2020;324:998–1000. doi: 10.1001/jama.2020.15301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.15301</ArticleId><ArticleId IdType="pmc">PMC7426882</ArticleId><ArticleId IdType="pubmed">32789492</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarleri J., Delpino M.V., Galvan V. Anticipating the Future of the COVID-19 Pandemic: Insights into the Emergence of SARS-CoV-2 Variant Jn.1 and Its Projected Impact on Older Adults. Geroscience. 2024;46:2879–2883. doi: 10.1007/s11357-024-01066-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-024-01066-7</ArticleId><ArticleId IdType="pmc">PMC11009205</ArticleId><ArticleId IdType="pubmed">38198026</ArticleId></ArticleIdList></Reference><Reference><Citation>Devera J.L., Gonzalez Y., Sabharwal V. A Narrative Review of COVID-19 Vaccination in Pregnancy and Breastfeeding. J Perinatol. 2024;44:12–19. doi: 10.1038/s41372-023-01734-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41372-023-01734-0</ArticleId><ArticleId IdType="pubmed">37495712</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes M.C., Kernberg A.S., Carter E.B., Foeller M.E., Palanisamy A., Raghuraman N., Kelly J.C. Pregnancy as a Risk Factor for Severe Coronavirus Disease 2019 Using Standardized Clinical Criteria. Am. J. Obstet. Gynecol. MFM. 2021;3:100319. doi: 10.1016/j.ajogmf.2021.100319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2021.100319</ArticleId><ArticleId IdType="pmc">PMC7826101</ArticleId><ArticleId IdType="pubmed">33493707</ArticleId></ArticleIdList></Reference><Reference><Citation>Surie D., Yuengling K.A., DeCuir J., Zhu Y., Gaglani M., Ginde A.A., Talbot H.K., Casey J.D., Mohr N.M., Ghamande S., et al. Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza among Hospitalized Adults Aged &gt;/=60 Years—Ivy Network, 20 U.S. States, February 2022–May 2023. MMWR Morb. Mortal. Wkly. Rep. 2023;72:1083–1088. doi: 10.15585/mmwr.mm7240a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7240a2</ArticleId><ArticleId IdType="pmc">PMC10564326</ArticleId><ArticleId IdType="pubmed">37796753</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras. N. Engl. J. Med. 2024;391:515–525. doi: 10.1056/NEJMoa2403211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2403211</ArticleId><ArticleId IdType="pubmed">39018527</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeworowski L.M., Muhlemann B., Walper F., Schmidt M.L., Jansen J., Krumbholz A., Simon-Loriere E., Jones T.C., Corman V.M., Drosten C. Humoral Immune Escape by Current SARS-CoV-2 Variants Ba.2.86 and Jn.1, December 2023. Euro Surveill. 2024;29:2300740. doi: 10.2807/1560-7917.ES.2024.29.2.2300740.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.2.2300740</ArticleId><ArticleId IdType="pmc">PMC10785204</ArticleId><ArticleId IdType="pubmed">38214083</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S., Bhattacharya M., Nag S., Dhama K., Chakraborty C. A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies. Viruses. 2023;15:167. doi: 10.3390/v15010167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010167</ArticleId><ArticleId IdType="pmc">PMC9866114</ArticleId><ArticleId IdType="pubmed">36680207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgensen S.B., Nygard K., Kacelnik O., Telle K. Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households. JAMA. 2022;327:1610–1611. doi: 10.1001/jama.2022.3780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.3780</ArticleId><ArticleId IdType="pmc">PMC8902690</ArticleId><ArticleId IdType="pubmed">35254379</ArticleId></ArticleIdList></Reference><Reference><Citation>Altarawneh H.N., Chemaitelly H., Hasan M.R., Ayoub H.H., Qassim S., AlMukdad S., Coyle P., Yassine H.M., Al-Khatib H.A., Benslimane F.M., et al. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N. Engl. J. Med. 2022;386:1288–1290. doi: 10.1056/NEJMc2200133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2200133</ArticleId><ArticleId IdType="pmc">PMC8849180</ArticleId><ArticleId IdType="pubmed">35139269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossler A., Riepler L., Bante D., von Laer D., Kimpel J. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons. N. Engl. J. Med. 2022;386:698–700. doi: 10.1056/NEJMc2119236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2119236</ArticleId><ArticleId IdType="pmc">PMC8781314</ArticleId><ArticleId IdType="pubmed">35021005</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Forecasting Team Past SARS-CoV-2 Infection Protection against Re-Infection: A Systematic Review and Meta-Analysis. Lancet. 2023;401:833–842. doi: 10.1016/S0140-6736(22)02465-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02465-5</ArticleId><ArticleId IdType="pmc">PMC9998097</ArticleId><ArticleId IdType="pubmed">36930674</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustsen-Helms I.R., Bager P., Larsen T.G., Moller F.T., Vestergaard L.S., Rasmussen M., Hansen C.H., SSI-DMC Study Group Relative Vaccine Protection, Disease Severity, and Symptoms Associated with the SARS-CoV-2 Omicron Subvariant Ba.2.86 and Descendant Jn.1 in Denmark: A Nationwide Observational Study. Lancet Infect. Dis. 2024;24:964–973. doi: 10.1016/S1473-3099(24)00220-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(24)00220-2</ArticleId><ArticleId IdType="pubmed">38761806</ArticleId></ArticleIdList></Reference><Reference><Citation>Huiberts A.J., Hoeve C.E., de Gier B., Cremer J., van der Veer B., de Melker H.E., van de Wijgert J.H., van den Hof S., Eggink D., Knol M.J. Effectiveness of Omicron Xbb.1.5 Vaccine against Infection with SARS-CoV-2 Omicron Xbb and Jn.1 Variants, Prospective Cohort Study, the Netherlands, October 2023 to January 2024. Euro Surveill. 2024;29:2400109. doi: 10.2807/1560-7917.ES.2024.29.10.2400109.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.10.2400109</ArticleId><ArticleId IdType="pmc">PMC10986669</ArticleId><ArticleId IdType="pubmed">38456217</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W.H., Cai H.L., Yan H.C., Wang H., Sun H.M., Wei Y.Y., Hao Y.T. Protective Effectiveness of Previous Infection against Subsequent SARS-Cov-2 Infection: Systematic Review and Meta-Analysis. Front. Public Health. 2024;12:1353415. doi: 10.3389/fpubh.2024.1353415.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2024.1353415</ArticleId><ArticleId IdType="pmc">PMC11222391</ArticleId><ArticleId IdType="pubmed">38966699</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.Y., Chiew C.J., Pang D., Lee V.J., Ong B., Lye D.C., Tan K.B. Protective Immunity of SARS-CoV-2 Infection and Vaccines against Medically Attended Symptomatic Omicron Ba.4, Ba.5, and Xbb Reinfections in Singapore: A National Cohort Study. Lancet Infect. Dis. 2023;23:799–805. doi: 10.1016/S1473-3099(23)00060-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00060-9</ArticleId><ArticleId IdType="pmc">PMC10306341</ArticleId><ArticleId IdType="pubmed">36924786</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H., Chen D., Li C., Huang T., Ma W. A Mini Review of Reinfection with the SARS-CoV-2 Omicron Variant. Health Sci. Rep. 2024;7:e2016. doi: 10.1002/hsr2.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.2016</ArticleId><ArticleId IdType="pmc">PMC11007061</ArticleId><ArticleId IdType="pubmed">38605725</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra A.R., Kobayashi T., Callado G.Y., Pardo I., Gutfreund M.C., Hsieh M.K., Lin V., Alsuhaibani M., Hasegawa S., Tholany J., et al. The Effectiveness of COVID-19 Vaccine in the Prevention of Post-COVID Conditions: A Systematic Literature Review and Meta-Analysis of the Latest Research. Antimicrob. Steward. Healthc. Epidemiol. 2023;3:e168. doi: 10.1017/ash.2023.447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ash.2023.447</ArticleId><ArticleId IdType="pmc">PMC10644173</ArticleId><ArticleId IdType="pubmed">38028898</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakkar K., Spinardi J., Kyaw M.H., Yang J., Mendoza C.F., Ozbilgili E., Taysi B., Dodd J., Yarnoff B., Oh H.M. Modelling the Potential Public Health Impact of Different COVID-19 Vaccination Strategies with an Adapted Vaccine in Singapore. Expert Rev. Vaccines. 2024;23:16–26. doi: 10.1080/14760584.2023.2290931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2023.2290931</ArticleId><ArticleId IdType="pubmed">38047434</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C., Bier B., Reed A.M., Paat J.J., Tu P. Changes in Confidence, Feelings, and Perceived Necessity Concerning COVID-19 Booster. Vaccines. 2023;11:1244. doi: 10.3390/vaccines11071244.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11071244</ArticleId><ArticleId IdType="pmc">PMC10383837</ArticleId><ArticleId IdType="pubmed">37515059</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Z., Li Q., Wu J., Zhu D., Bai J., Ren R., Zhang J., Li Y., Wang M., Gu J., et al. Dynamic Evolution of COVID-19 Vaccine Hesitancy over 2021–2023 among Chinese Population: Repeated Nationwide Cross-Sectional Study. J. Med. Virol. 2024;96:e29800. doi: 10.1002/jmv.29800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29800</ArticleId><ArticleId IdType="pubmed">39014958</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong W., Miao Y., Shen Z., Zhang W., Bai J., Zhu D., Ren R., Zhang J., Wu J., Tarimo C.S., et al. Quantifying Disparities in COVID-19 Vaccination Rates by Rural and Urban Areas: Cross-Sectional Observational Study. JMIR Public Health Surveill. 2024;10:e50595. doi: 10.2196/50595.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/50595</ArticleId><ArticleId IdType="pmc">PMC11297372</ArticleId><ArticleId IdType="pubmed">39028548</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus J.V., White T.M., Wyka K., Ratzan S.C., Rabin K., Larson H.J., Martinon-Torres F., Kuchar E., Abdool Karim S.S., Giles-Vernick T., et al. Influence of COVID-19 on Trust in Routine Immunization, Health Information Sources and Pandemic Preparedness in 23 Countries in 2023. Nat. Med. 2024;30:1559–1563. doi: 10.1038/s41591-024-02939-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02939-2</ArticleId><ArticleId IdType="pmc">PMC11186753</ArticleId><ArticleId IdType="pubmed">38684861</ArticleId></ArticleIdList></Reference><Reference><Citation>Betsch C., Schmid P., Heinemeier D., Korn L., Holtmann C., Bohm R. Beyond Confidence: Development of a Measure Assessing the 5c Psychological Antecedents of Vaccination. PLoS ONE. 2018;13:e0208601. doi: 10.1371/journal.pone.0208601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208601</ArticleId><ArticleId IdType="pmc">PMC6285469</ArticleId><ArticleId IdType="pubmed">30532274</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinou P., Kyprianidou M., Christodoulou A., McHugh L., Constantinou M., Epiphaniou E., Vahey N., Nicolaou C., Middleton N., Karekla M., et al. Behavioral, Cognitive and Emotional Determinants of Getting Vaccinated for COVID-19 and the Mediating Role of Institutional Trust among Young Adults in Cyprus. BMC Public Health. 2024;24:2336. doi: 10.1186/s12889-024-19859-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-024-19859-y</ArticleId><ArticleId IdType="pmc">PMC11351732</ArticleId><ArticleId IdType="pubmed">39198798</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshagrawi S.S. Predicting COVID-19 Vaccine Uptake: Comparing the Health Belief Model and Theory of Planned Behavior. Hum. Vaccines Immunother. 2024;20:2361503. doi: 10.1080/21645515.2024.2361503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2024.2361503</ArticleId><ArticleId IdType="pmc">PMC11253879</ArticleId><ArticleId IdType="pubmed">39007826</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan W.K.M. The Application of Behavioral Change Theories in Addressing Vaccine Hesitancy: A Literature Review. Public Health Nurs. 2024;41:318–324. doi: 10.1111/phn.13280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/phn.13280</ArticleId><ArticleId IdType="pubmed">38246855</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  Report of the Sage Working Group on Vaccine Hesitancy.  [(accessed on 21 October 2023)].  Available online:  https://cdn.who.int/media/docs/default-source/immunization/sage/2014/october/sage-working-group-revised-report-vaccine-hesitancy.pdf?sfvrsn=240a7c1c_4.</Citation></Reference><Reference><Citation>Melnikow J., Padovani A., Zhang J., Miller M., Gosdin M., Loureiro S., Daniels B. Patient Concerns and Physician Strategies for Addressing COVID-19 Vaccine Hesitancy. Vaccine. 2024;42:3300–3306. doi: 10.1016/j.vaccine.2024.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.04.025</ArticleId><ArticleId IdType="pubmed">38627148</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen C., Mosnier A., Gavazzi G., Combadiere B., Crepey P., Gaillat J., Launay O., Botelho-Nevers E. Coadministration of Seasonal Influenza and COVID-19 Vaccines: A Systematic Review of Clinical Studies. Hum. Vaccines Immunother. 2022;18:2131166. doi: 10.1080/21645515.2022.2131166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2131166</ArticleId><ArticleId IdType="pmc">PMC9746457</ArticleId><ArticleId IdType="pubmed">36256633</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydillo T., Balsera-Manzanero M., Rojo-Fernandez A., Escalera A., Salamanca-Rivera C., Pachon J., Del Mar Munoz-Garcia M., Sanchez-Cordero M.J., Sanchez-Cespedes J., Garcia-Sastre A., et al. Concomitant Administration of Seasonal Influenza and COVID-19 mRNA Vaccines. Emerg. Microbes Infect. 2024;13:2292068. doi: 10.1080/22221751.2023.2292068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2292068</ArticleId><ArticleId IdType="pmc">PMC10798284</ArticleId><ArticleId IdType="pubmed">38054302</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S., Nan X. Motivating COVID-19 Vaccination through Persuasive Communication: A Systematic Review of Randomized Controlled Trials. Health Commun. 2024;39:1455–1478. doi: 10.1080/10410236.2023.2218145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10410236.2023.2218145</ArticleId><ArticleId IdType="pubmed">37254940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijazi R., Gesser-Edelsburg A., Mesch G.S. Vaccine Communication Strategies among Healthcare Workers as a Reflection of the Israeli Ministry of Health’s Communication Strategies before and after the COVID-19 Pandemic. Front. Public Health. 2024;12:1377393. doi: 10.3389/fpubh.2024.1377393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2024.1377393</ArticleId><ArticleId IdType="pmc">PMC11153784</ArticleId><ArticleId IdType="pubmed">38846621</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein N., Schwarz K., Chan I., Kobau R., Alexander R., Kollar L., Rodriguez L., Mansergh G., Repetski T., Gandhi P., et al. COVID-19 Vaccine Hesitancy among Us Adults: Safety and Effectiveness Perceptions and Messaging to Increase Vaccine Confidence and Intent to Vaccinate. Public Health Rep. 2024;139:102–111. doi: 10.1177/00333549231204419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00333549231204419</ArticleId><ArticleId IdType="pmc">PMC10905758</ArticleId><ArticleId IdType="pubmed">37924246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher K.A., Nguyen N., Fouayzi H., Singh S., Crawford S., Mazor K.M. Impact of a Physician Recommendation on COVID-19 Vaccination Intent among Vaccine Hesitant Individuals. Patient Educ. Couns. 2023;106:107–112. doi: 10.1016/j.pec.2022.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2022.09.013</ArticleId><ArticleId IdType="pmc">PMC9523946</ArticleId><ArticleId IdType="pubmed">36244947</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman D., Loe B.S., Yu L.M., Freeman J., Chadwick A., Vaccari C., Shanyinde M., Harris V., Waite F., Rosebrock L., et al. Effects of Different Types of Written Vaccination Information on COVID-19 Vaccine Hesitancy in the Uk (Oceans-Iii): A Single-Blind, Parallel-Group, Randomised Controlled Trial. Lancet Public Health. 2021;6:e416–e427. doi: 10.1016/S2468-2667(21)00096-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00096-7</ArticleId><ArticleId IdType="pmc">PMC8116130</ArticleId><ArticleId IdType="pubmed">33991482</ArticleId></ArticleIdList></Reference><Reference><Citation>Byerley C.O., Horne D., Gong M., Musgrave S., Valaas L.A., Rickard B., Yoon H., Park M.S., Mirin A., Joshua S., et al. An Effective COVID-19 Vaccine Hesitancy Intervention Focused on the Relative Risks of Vaccination and Infection. Sci. Rep. 2024;14:7419. doi: 10.1038/s41598-024-57841-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-57841-1</ArticleId><ArticleId IdType="pmc">PMC10978892</ArticleId><ArticleId IdType="pubmed">38548828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher K.A., Singh S., Stone R.T., Nguyen N., Crawford S., Mazor K.M. Primary Care Providers’ Views of Discussing COVID-19 Vaccination with Vaccine Hesitant Patients: A Qualitative Study. Patient Educ. Couns. 2024;127:108369. doi: 10.1016/j.pec.2024.108369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pec.2024.108369</ArticleId><ArticleId IdType="pubmed">38996575</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri V., Wiedermann C.J., Lombardo S., Piccoliori G., Gartner T., Engl A. Evolving Altruistic Attitudes towards Vaccination Post COVID-19 Pandemic: A Comparative Analysis across Age Groups. Vaccines. 2024;12:454. doi: 10.3390/vaccines12050454.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12050454</ArticleId><ArticleId IdType="pmc">PMC11125754</ArticleId><ArticleId IdType="pubmed">38793705</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucette E.J., Pateman M., Fullerton M.M., Lip A., Houle S.K.D., Kellner J.D., Leal J., MacDonald S.E., McNeil D., Davidson S., et al. “You Can Push These Conversations, but Don’t Push Your Patient Away”: Healthcare Learner Perspectives on Virtual Simulation Games as an Educational Approach to Address Vaccine Hesitancy. Front. Public Health. 2024;12:1408871. doi: 10.3389/fpubh.2024.1408871.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2024.1408871</ArticleId><ArticleId IdType="pmc">PMC11252083</ArticleId><ArticleId IdType="pubmed">39022406</ArticleId></ArticleIdList></Reference><Reference><Citation>Doucette E.J., Fullerton M.M., Pateman M., Lip A., Houle S.K.D., Kellner J.D., Leal J., MacDonald S.E., McNeil D., Tyerman J., et al. Development and Evaluation of Virtual Simulation Games to Increase the Confidence and Self-Efficacy of Healthcare Learners in Vaccine Communication, Advocacy, and Promotion. BMC Med. Educ. 2024;24:190. doi: 10.1186/s12909-024-05169-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12909-024-05169-9</ArticleId><ArticleId IdType="pmc">PMC10895736</ArticleId><ArticleId IdType="pubmed">38403639</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes K., Colagiuri B. Positive Attribute Framing Increases COVID-19 Booster Vaccine Intention for Unfamiliar Vaccines. Vaccines. 2022;10:962. doi: 10.3390/vaccines10060962.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10060962</ArticleId><ArticleId IdType="pmc">PMC9229566</ArticleId><ArticleId IdType="pubmed">35746570</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudharsanan N., Favaretti C., Hachaturyan V., Barnighausen T., Vandormael A. Effects of Side-Effect Risk Framing Strategies on COVID-19 Vaccine Intentions: A Randomized Controlled Trial. Elife. 2022;11:e78765. doi: 10.7554/eLife.78765.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78765</ArticleId><ArticleId IdType="pmc">PMC9381035</ArticleId><ArticleId IdType="pubmed">35971757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hing N.Y.L., Woon Y.L., Lee Y.K., Kim H.J., Lothfi N.M., Wong E., Perialathan K., Ahmad Sanusi N.H., Isa A., Leong C.T., et al. When Do Persuasive Messages on Vaccine Safety Steer COVID-19 Vaccine Acceptance and Recommendations? Behavioural Insights from a Randomised Controlled Experiment in Malaysia. BMJ Glob. Health. 2022;7:e009250. doi: 10.1136/bmjgh-2022-009250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2022-009250</ArticleId><ArticleId IdType="pmc">PMC9344599</ArticleId><ArticleId IdType="pubmed">35906015</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanel K., Pedersen B., Albert Y.K., Ouattara M.L., Gbeke D., Ranebennur V., Burke H.M. Acceptability of an Incentivized Peer Referral Intervention to Address COVID-19 Vaccine Hesitancy among Adults in Yopougon-Est, Cote d’Ivoire. Glob. Health Sci. Pract. 2024;12:e2300468. doi: 10.9745/GHSP-D-23-00468.</Citation><ArticleIdList><ArticleId IdType="doi">10.9745/GHSP-D-23-00468</ArticleId><ArticleId IdType="pmc">PMC11216699</ArticleId><ArticleId IdType="pubmed">38724197</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascucci D., Lontano A., Regazzi L., Marziali E., Nurchis M.C., Raponi M., Vetrugno G., Moscato U., Cadeddu C., Laurenti P. Co-Administration of SARS-CoV-2 and Influenza Vaccines in Healthcare Workers: Results of Two Vaccination Campaigns in a Large Teaching Hospital in Rome. Hum. Vaccines Immunother. 2023;19:2287282. doi: 10.1080/21645515.2023.2287282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2287282</ArticleId><ArticleId IdType="pmc">PMC10732597</ArticleId><ArticleId IdType="pubmed">38016914</ArticleId></ArticleIdList></Reference><Reference><Citation>Batteux E., Bilovich A., Johnson S.G.B., Tuckett D. Negative Consequences of Failing to Communicate Uncertainties during a Pandemic: An Online Randomised Controlled Trial on COVID-19 Vaccines. BMJ Open. 2022;12:e051352. doi: 10.1136/bmjopen-2021-051352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-051352</ArticleId><ArticleId IdType="pmc">PMC9453426</ArticleId><ArticleId IdType="pubmed">36691187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugwuoke J.C., Talabi F.O., Adelabu O., Sanusi B.O., Gever V.C., Onuora C. Expanding the Boundaries of Vaccine Discourse: Impact of Visual Illustrations Communication Intervention on Intention towards COVID-19 Vaccination among Victims of Insecurity in Nigeria. Hum. Vaccines Immunother. 2021;17:3450–3456. doi: 10.1080/21645515.2021.1886558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.1886558</ArticleId><ArticleId IdType="pmc">PMC8437524</ArticleId><ArticleId IdType="pubmed">34128754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P., Tatar O., Griffin-Mathieu G., Perez S., Haward B., Zimet G., Tunis M., Dube E., Rosberger Z. The Efficacy of a Brief, Altruism-Eliciting Video Intervention in Enhancing COVID-19 Vaccination Intentions among a Population-Based Sample of Younger Adults: Randomized Controlled Trial. JMIR Public Health Surveill. 2022;8:e37328. doi: 10.2196/37328.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37328</ArticleId><ArticleId IdType="pmc">PMC9153910</ArticleId><ArticleId IdType="pubmed">35544437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumar K., Blue L., Fatahi G., Sumar M., Alvarez S., Cons P., Valencia N., Williams Z., Bhatti A., Parthasarathy S., et al. The Effect of Adding Physician Recommendation in Digitally-Enabled Outreach for COVID-19 Vaccination in Socially/Economically Disadvantaged Populations. BMC Public Health. 2024;24:1933. doi: 10.1186/s12889-024-18648-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-024-18648-x</ArticleId><ArticleId IdType="pmc">PMC11264853</ArticleId><ArticleId IdType="pubmed">39026196</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirshberg J.S., Huysman B.C., Oakes M.C., Cater E.B., Odibo A.O., Raghuraman N., Kelly J.C. Offering Onsite COVID-19 Vaccination to High-Risk Obstetrical Patients: Initial Findings. Am. J. Obstet. Gynecol. MFM. 2021;3:100478. doi: 10.1016/j.ajogmf.2021.100478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2021.100478</ArticleId><ArticleId IdType="pmc">PMC8411583</ArticleId><ArticleId IdType="pubmed">34481996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.C., Lee B.H., Lin Y.H., Wu B.J., Chen T.J., Chen W.M., Chen Y.C. Enhancing COVID-19 Booster Vaccination among the Elderly through Text Message Reminders. Hum. Vaccines Immunother. 2024;20:2375665. doi: 10.1080/21645515.2024.2375665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2024.2375665</ArticleId><ArticleId IdType="pmc">PMC11259076</ArticleId><ArticleId IdType="pubmed">39016157</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans W.D., Bingenheimer J.B., Long M.W., Ndiaye K., Donati D., Rao N.M., Akaba S., Agha S. Randomised Experimental Evaluation of a Social Media Campaign to Promote COVID-19 Vaccination in Nigeria. J. Glob. Health. 2024;14:05018. doi: 10.7189/jogh.14.05018.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.14.05018</ArticleId><ArticleId IdType="pmc">PMC11112529</ArticleId><ArticleId IdType="pubmed">38779876</ArticleId></ArticleIdList></Reference><Reference><Citation>Milkman K.L., Ellis S.F., Gromet D.M., Jung Y., Luscher A.S., Mobarak R.S., Paxson M.K., Silvera Zumaran R.A., Kuan R., Berman R., et al. Megastudy Shows that Reminders Boost Vaccination but Adding Free Rides Does Not. Nature. 2024;631:179–188. doi: 10.1038/s41586-024-07591-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07591-x</ArticleId><ArticleId IdType="pmc">PMC11222156</ArticleId><ArticleId IdType="pubmed">38926578</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawa T., Smith D., Andreeva D., Vaidya S., Kruja B., Farrell T., Ziemba A., Jones C., Travers A., Guilder A., et al. Inpatient COVID-19 Vaccination Rollout: Improving Access to Vaccination. Clin. Med. 2022;22:461–467. doi: 10.7861/clinmed.2022-0132.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2022-0132</ArticleId><ArticleId IdType="pmc">PMC9595007</ArticleId><ArticleId IdType="pubmed">36507810</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita A.W., Goolsby T.A., Powell K.M., Cartwright E.J. Increased Vaccine Uptake among Eligible Patients at a Veterans Affairs Hospital Through an Inpatient COVID-19 Vaccination Program, Atlanta, Georgia, 2021. Public Health Rep. 2024;139:94–101. doi: 10.1177/00333549231203238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00333549231203238</ArticleId><ArticleId IdType="pmc">PMC10905767</ArticleId><ArticleId IdType="pubmed">37924253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair S., Tshabalala K., Slingers N., Vanleeuw L., Basu D., Abdullah F. Feasibility of Provision and Vaccine Hesitancy at a Central Hospital COVID-19 Vaccination Site in South Africa after Four Waves of the Pandemic. Diseases. 2024;12:113. doi: 10.3390/diseases12060113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases12060113</ArticleId><ArticleId IdType="pmc">PMC11202450</ArticleId><ArticleId IdType="pubmed">38920545</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrou I., Hamilton K., Cook C., Armour C., Hughes S., Hancock J., Quigg S., Hajinur H., Srivastava S., Kenward C., et al. Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme. Vaccines. 2022;10:840. doi: 10.3390/vaccines10060840.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10060840</ArticleId><ArticleId IdType="pmc">PMC9227842</ArticleId><ArticleId IdType="pubmed">35746447</ArticleId></ArticleIdList></Reference><Reference><Citation>Micallef R., Matharu R., Barry A., Burgess V. Description of a Pharmacy COVID Champion Service in South East London to Reduce Vaccine Hesitancy. Pharmacy. 2022;10:143. doi: 10.3390/pharmacy10060143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmacy10060143</ArticleId><ArticleId IdType="pmc">PMC9680247</ArticleId><ArticleId IdType="pubmed">36412819</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber A., West J. Conditional Cash Lotteries Increase COVID-19 Vaccination Rates. J. Health Econ. 2022;81:102578. doi: 10.1016/j.jhealeco.2021.102578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhealeco.2021.102578</ArticleId><ArticleId IdType="pmc">PMC8685289</ArticleId><ArticleId IdType="pubmed">34986437</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpp K.G., Cannuscio C.C. Incentives for Immunity—Strategies for Increasing COVID-19 Vaccine Uptake. N. Engl. J. Med. 2021;385:e1. doi: 10.1056/NEJMp2107719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2107719</ArticleId><ArticleId IdType="pubmed">34038633</ArticleId></ArticleIdList></Reference><Reference><Citation>Skafle I., Nordahl-Hansen A., Quintana D.S., Wynn R., Gabarron E. Misinformation about COVID-19 Vaccines on Social Media: Rapid Review. J. Med. Internet Res. 2022;24:e37367. doi: 10.2196/37367.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/37367</ArticleId><ArticleId IdType="pmc">PMC9359307</ArticleId><ArticleId IdType="pubmed">35816685</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay S., Hacquin A.S., Chevallier C., Mercier H. Information Delivered by a Chatbot has a Positive Impact on COVID-19 Vaccines Attitudes and Intentions. J. Exp. Psychol. Appl. 2023;29:52–62. doi: 10.1037/xap0000400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/xap0000400</ArticleId><ArticleId IdType="pubmed">34726454</ArticleId></ArticleIdList></Reference><Reference><Citation>Luk T.T., Lui J.H.T., Wang M.P. Efficacy, Usability, and Acceptability of a Chatbot for Promoting COVID-19 Vaccination in Unvaccinated or Booster-Hesitant Young Adults: Pre-Post Pilot Study. J. Med. Internet Res. 2022;24:e39063. doi: 10.2196/39063.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/39063</ArticleId><ArticleId IdType="pmc">PMC9534274</ArticleId><ArticleId IdType="pubmed">36179132</ArticleId></ArticleIdList></Reference><Reference><Citation>Armand A., Fracchia M., Vicente P.C. Let’s Call! Using the Phone to Increase Vaccine Acceptance. Health Econ. 2024;33:82–106. doi: 10.1002/hec.4760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.4760</ArticleId><ArticleId IdType="pubmed">37792290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Lilani A., Redemptus C., Campana K., Tozan Y. A Pre-Post Evaluation Study of a Social Media-Based COVID-19 Communication Campaign to Improve Attitudes and Behaviors toward COVID-19 Vaccination in Tanzania. PLoS ONE. 2024;19:e0300206. doi: 10.1371/journal.pone.0300206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0300206</ArticleId><ArticleId IdType="pmc">PMC11073716</ArticleId><ArticleId IdType="pubmed">38709712</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Qu Z., Tu S., Chen X., Hou Z. The Whole-of-Society Approach of Mass COVID-19 Vaccination in China: A Qualitative Study. Health Res. Policy Syst. 2022;20:142. doi: 10.1186/s12961-022-00947-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12961-022-00947-7</ArticleId><ArticleId IdType="pmc">PMC9802023</ArticleId><ArticleId IdType="pubmed">36585666</ArticleId></ArticleIdList></Reference><Reference><Citation>Astuti S.I., Sufehmi H., Wilhelm E. Centring Health Workers and Communities Is Key to Building Vaccine Confidence Online. BMJ. 2024;384:q82. doi: 10.1136/bmj.q82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.q82</ArticleId><ArticleId IdType="pubmed">38228338</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Shiu Cheong D., Tran J., Chong W., May S., Carlson S.J., Salter S.M., Attwell K. Attitudes, Perceptions, and Experiences of Western Australians towards Vaccine Safety Surveillance Systems Following COVID-19 Vaccines: A qualitative Descriptive Study. Aust. N. Z. J. Public Health. 2024;48:100177. doi: 10.1016/j.anzjph.2024.100177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anzjph.2024.100177</ArticleId><ArticleId IdType="pubmed">39029385</ArticleId></ArticleIdList></Reference><Reference><Citation>Begum T., Efstathiou N., Bailey C., Guo P. Cultural and Social Attitudes towards COVID-19 Vaccination and Factors Associated with Vaccine Acceptance in Adults across the Globe: A Systematic Review. Vaccine. 2024;42:125993. doi: 10.1016/j.vaccine.2024.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.05.041</ArticleId><ArticleId IdType="pubmed">38806355</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallah N., Pardo-Seco J., Rivero-Calle I., Zhu-Huang O., Fernandez Prada M., Reynen-de Kat C., Benes O., Mosina L., Sankar-Datta S., Aleksinskaya O., et al. COVID-19 Infovaccines: A Who-Supported Educational Project to Promote COVID-19 Vaccination Information among Professionals and the General Population. Hum. Vaccines Immunother. 2024;20:2350817. doi: 10.1080/21645515.2024.2350817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2024.2350817</ArticleId><ArticleId IdType="pmc">PMC11123498</ArticleId><ArticleId IdType="pubmed">38782400</ArticleId></ArticleIdList></Reference><Reference><Citation>Denoble A.E., Vazquez-Benitez G., Sheth S.S., Ackerman-Banks C.M., DeSilva M.B., Zhu J., Daley M.F., Getahun D., Klein N.P., Vesco K.K., et al. Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstet. Gynecol. 2024;144:215–222. doi: 10.1097/AOG.0000000000005632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000005632</ArticleId><ArticleId IdType="pmc">PMC11250101</ArticleId><ArticleId IdType="pubmed">38843526</ArticleId></ArticleIdList></Reference><Reference><Citation>Duradoni M., Gursesli M.C., Materassi L., Serritella E., Guazzini A. The Long-COVID Experience Changed People’s Vaccine Hesitancy but Not Their Vaccination Fear. Int. J. Environ. Res. Public Health. 2022;19:4550. doi: 10.3390/ijerph192114550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192114550</ArticleId><ArticleId IdType="pmc">PMC9654193</ArticleId><ArticleId IdType="pubmed">36361430</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen K.H., McChesney C., Patel R., Bednarczyk R.A., Vasudevan L., Corlin L. Association between COVID-19 Booster Vaccination and COVID-19 Outcomes among U.S. Adults. Vaccines. 2024;12:503. doi: 10.3390/vaccines12050503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines12050503</ArticleId><ArticleId IdType="pmc">PMC11125699</ArticleId><ArticleId IdType="pubmed">38793754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>